Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00617916 · ClinicalTrials.gov registry record
Hyperspectral Imaging to Assess and Predict Diabetic Foot Ulcers
A clinical trial of Diabetic Foot Ulcers, sponsored by HyperMed.
- Completed
- Registry status
- 256
- Enrollment target
- 3
- Study locations
NCT00617916: Completed study of Diabetic Foot Ulcers, sponsored by HyperMed.
NCT00617916 is a study of Diabetic Foot Ulcers that has completed, run by HyperMed. The registered enrollment target is 256 participants, above the 213-participant average among 12 other Diabetic Foot Ulcers trials with a reported enrollment target (20% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00617916, a study of Diabetic Foot Ulcers, has completed, sponsored by HyperMed.
- COMPLETED
- Registry status
- 256 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study is designed to test a prototype imaging instrument that relies on Medical HyperSpectral Imaging (MHSI) technology for the assessment and prediction of diabetic foot ulceration and wound healing. The imaging system utilizes the biomarkers of oxyhemoglobin (oxyHb) and deoxyhemoglobin (deoxyHb), in the upper layers of skin on the foot as: a metric for assessing wound healing, a reflection of microvascular disease, and determining tissue at risk for forming new ulcers. MHSI results will also be compare with ABI and TcPO2 measurements.
Conditions Studied
Study Locations (3)
California
- Olive View UCLA Medical Center - Sylmar
Ohio
- Lerner Research Institute, The Cleveland Clinic - Cleveland
Pennsylvania
- University of Pennslyvania Healthcare System - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 256 participants |
| Start Date | 2006-03 |
| Est. Completion | 2008-09 |
What the finished NCT00617916 record still lists
NCT00617916 is an observational study that tracks outcomes without assigning an intervention. The registered 256 participants enrollment target is mid-sized for trials with a published cap, above the 213-participant average among 12 other Diabetic Foot Ulcers trials with a reported enrollment target (20% higher).
The record links to 1 condition, with Diabetic Foot Ulcers appearing as the primary indexed condition, and to 0 interventions.
NCT00617916 reports a single indexed study location in California, Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00617916 about?
NCT00617916 is a clinical study titled "Hyperspectral Imaging to Assess and Predict Diabetic Foot Ulcers". This study is designed to test a prototype imaging instrument that relies on Medical HyperSpectral Imaging (MHSI) technology for the assessment and prediction of diabetic foot ulceration and wound healing. The imaging system utilizes the biomarkers of oxyhemoglobin (oxyHb) and deoxyhemoglobin (deoxy...
What is the current status of trial NCT00617916?
This trial is currently completed. The enrollment target is 256 participants. The study started on 2006-03. Estimated completion is 2008-09.
What conditions does trial NCT00617916 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcers.
Who is sponsoring clinical trial NCT00617916?
This trial is sponsored by HyperMed, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00617916 being conducted?
This trial has 3 study locations across California, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00617916's enrollment target sits among peer trials
256 4th of 12 higher than 9 of 12 other Diabetic Foot Ulcers trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Foot Ulcers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers
ACTIVE NOT RECRUITING · Phase 2
-
Wound Healing Endpoint and Recurrence
ACTIVE NOT RECRUITING · Phase 1
-
Clinical Trials of Footwear in Patients With Diabetes-Study Arm 2,3
COMPLETED · Phase 2
-
A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk
COMPLETED
-
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Diabetic Foot Ulcers
COMPLETED · Phase 1
-
MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02464696 · 256 participants · NA
Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure
- NCT03793062 · 256 participants
Genetic and Epigenetic Basis of Chronic Wounds
- NCT04322318 · 256 participants · Phase 2
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- NCT04468360 · 256 participants · Phase 2
Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia